Chengyong Qin

1.1k total citations
51 papers, 847 citations indexed

About

Chengyong Qin is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Chengyong Qin has authored 51 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 21 papers in Cancer Research and 10 papers in Epidemiology. Recurrent topics in Chengyong Qin's work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (7 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Chengyong Qin is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (7 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Chengyong Qin collaborates with scholars based in China, United States and United Kingdom. Chengyong Qin's co-authors include Jianni Qi, Qi Zhao, Jiyong Liu, Juan Liu, Chunqing Zhang, Wanhua Ren, Juan Liu, Guoquan Zhang, Tao Li and Lin Xu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Chengyong Qin

51 papers receiving 837 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengyong Qin China 18 396 341 187 174 156 51 847
Xinqiang Huang United States 14 803 2.0× 373 1.1× 174 0.9× 121 0.7× 171 1.1× 17 1.2k
Lianbao Kong China 17 334 0.8× 247 0.7× 195 1.0× 154 0.9× 98 0.6× 46 760
Hengyu Li China 12 361 0.9× 188 0.6× 114 0.6× 136 0.8× 138 0.9× 32 736
Daichi Ishikawa Japan 20 340 0.9× 189 0.6× 207 1.1× 147 0.8× 109 0.7× 48 851
Yong Jiang China 21 585 1.5× 460 1.3× 324 1.7× 85 0.5× 134 0.9× 71 1.3k
Xiaokun Ma China 18 355 0.9× 281 0.8× 107 0.6× 212 1.2× 292 1.9× 70 1.1k
Hisaaki Miyoshi Japan 16 407 1.0× 177 0.5× 177 0.9× 130 0.7× 191 1.2× 40 803
Yifu He China 16 283 0.7× 191 0.6× 97 0.5× 92 0.5× 131 0.8× 78 717
Chen Huang China 16 326 0.8× 214 0.6× 146 0.8× 133 0.8× 85 0.5× 38 843
Tomoko Tadokoro Japan 20 400 1.0× 275 0.8× 90 0.5× 224 1.3× 286 1.8× 74 933

Countries citing papers authored by Chengyong Qin

Since Specialization
Citations

This map shows the geographic impact of Chengyong Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengyong Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengyong Qin more than expected).

Fields of papers citing papers by Chengyong Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengyong Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengyong Qin. The network helps show where Chengyong Qin may publish in the future.

Co-authorship network of co-authors of Chengyong Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Chengyong Qin. A scholar is included among the top collaborators of Chengyong Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengyong Qin. Chengyong Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gong, Qi, Yuxing Wang, Tong Feng, et al.. (2023). CUL4B enhances the malignant phenotype of esophageal squamous cell carcinoma by suppressing TGFBR3 expression. Biochemical and Biophysical Research Communications. 676. 58–65. 4 indexed citations
2.
Song, Lulu, et al.. (2022). Long noncoding RNA Ftx regulates the protein expression profile in HCT116 human colon cancer cells. Proteome Science. 20(1). 7–7. 5 indexed citations
3.
Wu, Hao, et al.. (2020). Four Autophagy‐Related lncRNAs Predict the Prognosis of HCC through Coexpression and ceRNA Mechanism. BioMed Research International. 2020(1). 3801748–3801748. 31 indexed citations
4.
Liu, Tiantian, Hao Wu, Jianni Qi, Chengyong Qin, & Qiang Zhu. (2020). Seven immune‐related genes prognostic power and correlation with tumor‐infiltrating immune cells in hepatocellular carcinoma. Cancer Medicine. 9(20). 7440–7452. 29 indexed citations
5.
Sun, Hongsheng, et al.. (2020). Gene testing for osteonecrosis of the femoral head in systemic lupus erythematosus using targeted next-generation sequencing: A pilot study. World Journal of Clinical Cases. 8(12). 2530–2541. 8 indexed citations
6.
Zhang, Junyong, et al.. (2019). Quantitative Proteomics Analysis Revealed the Potential Role of lncRNA Ftx in Promoting Gastric Cancer Progression. PROTEOMICS - CLINICAL APPLICATIONS. 14(1). e1900053–e1900053. 13 indexed citations
7.
Li, Xiao, Qi Zhao, Jianni Qi, et al.. (2018). lncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPARγ pathway in hepatocellular carcinoma. International Journal of Oncology. 53(2). 551–566. 56 indexed citations
8.
Liu, Juan & Chengyong Qin. (2018). VX-680 induces p53-mediated apoptosis in human cholangiocarcinoma cells. Anti-Cancer Drugs. 29(10). 1004–1010. 5 indexed citations
9.
Li, Feifei, Hongjun Bian, Wenwen Wang, et al.. (2018). HBV infection suppresses the expression of inflammatory macrophage miR‑210. Molecular Medicine Reports. 19(3). 1833–1839. 10 indexed citations
10.
Qin, Chengyong, et al.. (2017). Interleukin 35 Rescues Regulatory B Cell Function, but the Effect Is Dysregulated in Ulcerative Colitis. DNA and Cell Biology. 36(5). 413–421. 11 indexed citations
11.
Li, Jie, et al.. (2014). Interleukin-21 Responses in Patients with Chronic Hepatitis B. Journal of Interferon & Cytokine Research. 35(2). 134–142. 10 indexed citations
12.
Huang, Huimin, et al.. (2014). Danshensu-mediated protective effect against hepatic fibrosis induced by carbon tetrachloride in rats. Pathologie Biologie. 62(6). 348–353. 19 indexed citations
13.
Ren, Peng, et al.. (2014). MicroRNAs as a novel class of diagnostic biomarkers in detection of hepatocellular carcinoma: a meta-analysis. Tumor Biology. 35(12). 12317–12326. 11 indexed citations
14.
Jiang, Man, Haijian Wu, & Chengyong Qin. (2013). Genetic Variant rs401681 at 5p15.33 Modifies Susceptibility to Lung Cancer but Not Esophageal Squamous Cell Carcinoma. PLoS ONE. 8(12). e84277–e84277. 8 indexed citations
15.
Li, Tao, et al.. (2012). Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma. Journal of Clinical Pathology. 65(9). 808–814. 26 indexed citations
16.
Wang, Jing, Shulei Zhao, Yan Li, Mei Meng, & Chengyong Qin. (2012). 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Induces Retinoic Acid Receptor β Hypermethylation through DNA Methyltransferase 1 Accumulation in Esophageal Squamous Epithelial Cells. Asian Pacific Journal of Cancer Prevention. 13(5). 2207–2212. 18 indexed citations
17.
Li, Feifei, et al.. (2012). Downregulation of GRIM-19 is associated with hyperactivation of p-STAT3 in hepatocellular carcinoma. Medical Oncology. 29(5). 3046–3054. 23 indexed citations
18.
Li, Bin, et al.. (2009). Advances in calcium-binding protein S100A4 and digestive neoplasms. World Chinese Journal of Digestology. 17(8). 805–805. 1 indexed citations
19.
Liu, Hui, et al.. (2008). Synthetic chenodeoxycholic acid derivative, HS-1200, induces apoptosis of human hepatoma cells via a mitochondrial pathway. Cancer Letters. 270(2). 242–249. 20 indexed citations
20.
Liu, Jiyong, Hongwei Xu, Yi Cui, et al.. (2006). Influence of antitumor drugs on the expression of Fas system in SW480 colon cancer cells. European Journal of Gastroenterology & Hepatology. 18(10). 1071–1077. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xinqiang Huang Breakdown of academic impact, for papers by Lianbao Kong Breakdown of academic impact, for papers by Hengyu Li Breakdown of academic impact, for papers by Daichi Ishikawa Breakdown of academic impact, for papers by Yong Jiang Breakdown of academic impact, for papers by Xiaokun Ma Breakdown of academic impact, for papers by Hisaaki Miyoshi Breakdown of academic impact, for papers by Yifu He Breakdown of academic impact, for papers by Chen Huang Breakdown of academic impact, for papers by Tomoko Tadokoro
Rankless by CCL
2026